Real-time enrollment status for this multiple myeloma clinical trial
Current Status
Recruiting
Checked: March 2, 2026 at 8:48 AM UTC
| NCT Number | NCT02343042 |
| Recruiting Status | Recruiting |
| Condition | Multiple Myeloma |
| Phase | Clinical Trial |
| Target Enrollment | 300 participants |
| Active Locations | 15 sites in the US |
| Sponsor | Karyopharm Therapeutics Inc |
| Last Updated on CT.gov | December 22, 2025 (Dec 22, 2025) |
As of March 2, 2026: Clinical trial NCT02343042 is currently recruiting participants. This clinical trial study for multiple myeloma is actively seeking new participants at 15 locations across the United States. The study is sponsored by Karyopharm Therapeutics Inc. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT02343042 is actively recruiting participants as of March 2, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 15 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT02343042 was last updated Dec 22, 2025 (December 22, 2025). HelloStudys verifies this status automatically.